AMGN

Peter H. Griffith

Known title: EVP & CFOCIK: 0001798821

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

Amgen Outperforms Market Amid Dow Jones Rotation. Amgen has recently exceeded broader market returns, a trend highlighted in recent analyses of Dow Jones stocks making bullish moves during defensive market rotations. This performance contrasts with peers like Merck, where analysts are comparing dividend growth potential. While the stock shows relative strength, it remains within its 52-week range, with the average analyst target price set significantly above current levels.

this person other insiders at AMGN

Transaction History

AMGN▼ Sell$184K
AMGN▼ Sell$165K
AMGN▲ Buy$0
AMGN▼ Sell$246K
AMGN▼ Sell$227K
AMGN▼ Sell$2.1M
AMGN▲ Buy$0
AMGN▲ Buy$0
AMGN▼ Sell$199K
AMGN▼ Sell$189K
AMGN▼ Sell$185K
AMGN▼ Sell$1.0M
AMGN▲ Buy$0
AMGN▲ Buy$0
AMGN▼ Sell$202K
AMGN▼ Sell$189K
AMGN▼ Sell$167K
AMGN▼ Sell$1.4M
AMGN▲ Buy$0
AMGN▼ Sell$895K
AMGN▼ Sell$141K
AMGN▲ Buy$0
AMGN▼ Sell$140K
AMGN▼ Sell$798K
AMGN▲ Buy$0
AMGN▼ Sell$819K
AMGN▼ Sell$139K
AMGN▲ Buy$0
AMGN▼ Sell$551K

We use analytics to understand how market-wall is used. No personal data is sold.